Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.7759/cureus.11186 http://scihub22266oqcxt.onion/10.7759/cureus.11186 33133803!7593204!33133803     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33133803&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Cureus 2020 ; 12 (10): e11186 Nephropedia Template TP {{tp|p=33133803|t=2020. Fatal Rhabdomyolysis in a COVID-19 Patient on Rosuvastatin |pdf=|usr=}}{{33133803}} gab.com Text Fatal Rhabdomyolysis in a COVID-19 Patient on Rosuvastatin JO: Cureus http://www.kidney.de/pget.php?&tw=1&pmid=33133803 #FOAvip It is well-established by now that COVID-19 can have a wide variety of neuromuscular manifestations, including rhabdomyolysis. Weakness and elevated creatinine kinase (CK) have been documented as the initial presentation of COVID-19. Myopathy from statin use has also been well-established since the introduction of this class of medication, and the common pathologic mechanism of both entities may have been mitochondrial dysfunction. We present here the case of a COVID-19 patient on rosuvastatin who developed rhabdomyolysis with CK above 1,000,000 units/L. The patient did not present with any respiratory difficulty and responded poorly to treatment, resulting in his untimely demise. COVID-19 may have accentuated an otherwise survivable condition by means of extra stress on mitochondrial homeostasis. Understanding the actual mechanism will be important in the development and utilization of medications in the fight against COVID-19. Twit Text FOAVip Fatal Rhabdomyolysis in a COVID-19 Patient on Rosuvastatin ????Cureus http://www.kidney.de/pget.php?&tw=1&pmid=33133803 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33133803 #FOAvip English Wikipedia <ref>{{Cite pmid|33133803}}</ref> Fatal Rhabdomyolysis in a COVID-19 Patient on Rosuvastatin #MMPMID33133803 Anklesaria Z; Frankman J; Gordin J; Zhan J; Liu AK Cureus 2020[Oct]; 12 (10): e11186 PMID33133803show ga It is well-established by now that COVID-19 can have a wide variety of neuromuscular manifestations, including rhabdomyolysis. Weakness and elevated creatinine kinase (CK) have been documented as the initial presentation of COVID-19. Myopathy from statin use has also been well-established since the introduction of this class of medication, and the common pathologic mechanism of both entities may have been mitochondrial dysfunction. We present here the case of a COVID-19 patient on rosuvastatin who developed rhabdomyolysis with CK above 1,000,000 units/L. The patient did not present with any respiratory difficulty and responded poorly to treatment, resulting in his untimely demise. COVID-19 may have accentuated an otherwise survivable condition by means of extra stress on mitochondrial homeostasis. Understanding the actual mechanism will be important in the development and utilization of medications in the fight against COVID-19. ?Fatal Rhabdomyolysis in a COVID-19 Patient on Rosuvastatin (epmc).pdf DeepDyve Pubget Overpricing